Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch. …

An Oklahoma judge has declined to approve a proposed $85 million settlement between the state and Teva Pharmaceuticals (TEVA) until he is assured it complies with a new law targeting such deals, the Associated Press writes. Cleveland County Judge Thad Balkman ordered attorneys for both the state and Teva to file additional paperwork before he approves the settlement. Concerned about how the state’s $270 million settlement with Purdue Pharmaceuticals was structured, the Republican-led legislature passed a law directing any settlement funds directly into the state treasury.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • And here we are now, in Florida and in the national debate, where instead of using science / public health data to make the argument – “DeSantis has insisted his close relationship with President Trump would help win over skeptical federal officials …”

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy